BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30879010)

  • 1. Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report.
    Chiang MC; McDowell MM; Weaver K; Broniscer A; Greene S
    Pediatr Neurosurg; 2019; 54(3):201-206. PubMed ID: 30879010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
    Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
    Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
    Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
    J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
    Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
    Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
    Mitchell BJ; Rogers GF; Wood BC
    J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.
    Pan C; Zhou X; Hong A; Fang F; Wang Y
    BMC Med Genomics; 2020 Dec; 13(1):188. PubMed ID: 33308209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
    Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
    J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
    Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
    Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MAP-kinase pathway activation in nevus sebaceous and Schimmelpenning syndrome].
    Dereure O
    Ann Dermatol Venereol; 2013 Apr; 140(4):326-7. PubMed ID: 23567237
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities.
    Watanabe Y; Shido K; Niihori T; Niizuma H; Katata Y; Iizuka C; Oba D; Moriya K; Saito-Nanjo Y; Onuma M; Rikiishi T; Sasahara Y; Watanabe M; Aiba S; Saito R; Sonoda Y; Tominaga T; Aoki Y; Kure S
    Am J Med Genet A; 2016 Jan; 170A(1):189-94. PubMed ID: 26360803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
    Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
    Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
    Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
    Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
    Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
    J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
    Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
    Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance for Schimmelpenning-Feuerstein-Mims syndrome in monochorionic twins supports the concept of a postzygotic mutation.
    Rijntjes-Jacobs EG; Lopriore E; Steggerda SJ; Kant SG; Walther FJ
    Am J Med Genet A; 2010 Nov; 152A(11):2816-9. PubMed ID: 20949522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phacomatosis pigmentokeratotica: Postzygotic HRAS mutation with malignant degeneration of the sebaceous naevus.
    Cranwell WC; Walsh M; Winship I
    Australas J Dermatol; 2019 Aug; 60(3):e245-e246. PubMed ID: 30767209
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
    Minowa T; Kamiya T; Hida T; Okura M; Kato J; Idogawa M; Tange S; Hirano T; Tokino T; Uhara H
    J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a recurrent mosaic
    Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
    Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
    Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
    Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.